在三臂试验中对治疗组合的III期评估
Edward L Korn1, Carmen J Allegra2,3, Boris Freidlin1
1Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
概括
大多数癌症试验并没有正式将组合治疗 (AB) 与实验性治疗 (A) 进行比较. 这项研究调查了试验设计,并建议改善统计学上可靠的治疗建议.
科学领域:
- 在瘤学瘤学.
- 临床试验设计 临床试验设计
- 生物统计学 生物统计学
背景情况:
- 第三期癌症试验经常比较对照 (C),实验性治疗 (A) 或组合 (AB).
- 目标是确定优越的治疗方法:AB,A或C.
- 在推最佳治疗时,获得统计学上的信心可能是具有挑战性的.
研究的目的:
- 评估当前的第三阶段癌症试验设计,以进行治疗比较.
- 识别试验设计中可能阻碍最佳治疗选择的缺陷.
- 提出改善试验设计和分析策略的建议.
主要方法:
- 在五个主要期刊上发表的癌症试验调查 (2018年1月 - 2024年5月).
- 试验设计的分析,重点是组合 (AB) 和实验 (A) 治疗臂之间的比较.
- 有限的模拟用于评估分析策略,包括AB对A比较.
主要成果:
- 四分之三的受访试验缺乏组合 (AB) 和实验 (A) 治疗臂之间的正式比较.
- 这种遗漏代表了试验设计中的潜在缺陷.
- 模拟探索了解决这一差距的策略.
结论:
- 目前的第三期癌症试验设计经常忽略了组合疗法和实验疗法之间的关键比较.
- 需要改进的试验设计,包括正式的AB与A比较.
- 提供了建议,以提高在确定最佳癌症治疗的统计信心.
相关概念视频
Hazard Ratio
91
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
91
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Comparing the Survival Analysis of Two or More Groups
155
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
155
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121
Mitral Regurgitation III: Medical Management
4
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
4


